Non-alcoholic fatty liver disease in lean individuals - PubMed (original) (raw)
Review
Non-alcoholic fatty liver disease in lean individuals
Somaya Albhaisi et al. JHEP Rep. 2019.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease, encompassing a spectrum from non-alcoholic fatty liver to non-alcoholic steatohepatitis, which can progress to cirrhosis. It has recently been recognised that NAFLD also occurs in individuals who are not obese, especially in Asian populations. In these patients, NAFLD manifests at lower overall body mass index thresholds in the presence of increased visceral adipose tissue. Currently, the principles of clinical management are similar to those in obese individuals, although, in specific regions and clinical situations, unique aetiologies of NAFLD must be treated specifically.
© 2019 The Authors.
Figures
Fig. 1
Pathophysiological concepts underlying development of NASH in non-obese individuals. BMI, body mass index; NASH, non-alcoholic steatohepatitis.
References
- Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20. - PubMed
- Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38:954–961. - PubMed
- Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 2012;91:319–327. - PubMed
- Wei JL, Leung JC, Loong TC, Wong GL, Yeung DK, Chan RS. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy. Am J Gastroenterol. 2015;110:1306–1314. quiz 1315. - PubMed
Publication types
LinkOut - more resources
Full Text Sources